PT-141 Price: Cost per mg and per Week
What PT-141 costs per mg by vial size, from dated public listings. No vendor links, no coupons.
Price per mg
Why prices vary
- Brand-name prices depend on insurance coverage, manufacturer programs and pharmacy; compounded versions are priced differently.
- Bigger vials usually cost less per mg, but only if the whole vial is used before it expires.
- Prices change often, which is why every figure here carries the date it was checked.
Price data
The price file has 0 observation rows for PT-141, so no price is published.
Calculated from raw observation rows 0; min distinct sellers 3; dataset checked 2026-10-02. Formula: published sizes = sizes with at least 3 distinct sellers whose price was still on the page at the re-fetch; rows counted in research/sourced/market/prices/observations.csv
Regulatory status
Drugs@FDA lists bremelanotide as Vyleesi, a prescription autoinjector.[2]
What studies found
In two phase 3 trials in premenopausal women with hypoactive sexual desire disorder, bremelanotide raised sexual desire scores more than placebo: 0.30 in study 301, 0.42 in study 302 and 0.35 combined (all P<.001).[5]
Common questions
How much does PT-141 cost?
We publish price per mg only from dated, public listings. We have not collected enough listings for PT-141 to publish a figure. We never link to sellers.
Where can I buy PT-141?
The approved product is available by prescription from a pharmacy. We don't link to or rank online sellers.
vyleesi cost?
Vyleesi (bremelanotide) is an FDA-approved prescription autoinjector, listed in Drugs@FDA.[2]
pt 141 for sale?
No price is published for PT-141: a vial size is listed only when at least 3 distinct sellers have been recorded, and none has been.
Calculated from raw observation rows 0; min distinct sellers 3. Formula: published sizes require at least 3 distinct sellers
More on PT-141
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2United States: Approved by FDA as Vyleesi (bremelanotide), Cosette, original approval 21 June 2019, for premenopausal women with acquired, generalized hypoactive sexual desire disorder (label quote).U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 3FDA warning letters to five research-peptide sellersFDA warning letter (NuScience Peptides; 1 of 5) · 2026fda.govAccessed 2 Oct 2026
- 4These highlights do not include all the information needed to use VYLEESI ® safely and effectively. See full prescribing information for VYLEESI VYLEESI (bremelanotide injection), for subcutaneous use Initial U.S. Approval: 2019FDA label (Vyleesi), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 5Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.Obstetrics and gynecology · 2019PMID 31599840Accessed 2 Oct 2026
Found an error? Report a correction.